Condition: Transitional cell carcinoma of bladder
rs121913338
in
BRAF
gene and
Transitional cell carcinoma of bladder
PMID 26619011
2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs1057519881
in
CDKN2A
gene and
Transitional cell carcinoma of bladder
PMID 26619011
2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs1057519956
in
CNOT9
gene and
Transitional cell carcinoma of bladder
PMID 26619011
2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs1057519884
in
CREBBP
gene and
Transitional cell carcinoma of bladder
PMID 26619011
2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs1057519886
in
CTNNB1
gene and
Transitional cell carcinoma of bladder
PMID 26619011
2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs1057519889
in
EP300
gene and
Transitional cell carcinoma of bladder
PMID 26619011
2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs1057519816
in
ERBB2
gene and
Transitional cell carcinoma of bladder
PMID 26619011
2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs1057519891
in
ERBB3
gene and
Transitional cell carcinoma of bladder
PMID 26619011
2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs1057519896
in
FBXW7
gene and
Transitional cell carcinoma of bladder
PMID 26619011
2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs1057519897
in
FGFR1
gene and
Transitional cell carcinoma of bladder
PMID 26619011
2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs121913482
in
FGFR3
gene and
Transitional cell carcinoma of bladder
PMID 26619011
2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs104894230
in
HRAS;LRRC56
gene and
Transitional cell carcinoma of bladder
PMID 26619011
2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs121913499
in
IDH1
gene and
Transitional cell carcinoma of bladder
PMID 26619011
2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs17851045
in
KRAS
gene and
Transitional cell carcinoma of bladder
PMID 26619011
2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs104894226
in
LRRC56;HRAS
gene and
Transitional cell carcinoma of bladder
PMID 26619011
2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs1057519732
in
MAP2K1
gene and
Transitional cell carcinoma of bladder
PMID 26619011
2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs1057519911
in
MAPK1
gene and
Transitional cell carcinoma of bladder
PMID 26619011
2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs1057519780
in
MTOR
gene and
Transitional cell carcinoma of bladder
PMID 24625776
2014 Activating mTOR mutations in a patient with an extraordinary response on a phase I trial of everolimus and pazopanib.
rs1057519920
in
NFE2L2
gene and
Transitional cell carcinoma of bladder
PMID 26619011
2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs11554290
in
NRAS
gene and
Transitional cell carcinoma of bladder
PMID 26619011
2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs104886003
in
PIK3CA
gene and
Transitional cell carcinoma of bladder
PMID 26619011
2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs1057519949
in
RHEB
gene and
Transitional cell carcinoma of bladder
PMID 26619011
2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs1057519958
in
RXRA
gene and
Transitional cell carcinoma of bladder
PMID 26619011
2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs1057519961
in
SF3B1
gene and
Transitional cell carcinoma of bladder
PMID 26619011
2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs1057519975
in
TP53
gene and
Transitional cell carcinoma of bladder
PMID 26619011
2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
rs371769427
in
U2AF1
gene and
Transitional cell carcinoma of bladder
PMID 26619011
2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.